Collin D. Ingram,Morag A. Grassie,Nicol Ferrier,Sasha E. Gartside,Allan H. Young
申请号：
US13865259
公开号：
US20130231316A1
申请日:
2013.04.18
申请国别(地区):
US
年份:
2013
代理人:
摘要：
The invention provides for a combination comprising an amount of an SSRI, or a pharmaceutically acceptable salt or solvate thereof, and an amount of a GR antagonist, or a pharmaceutically acceptable salt or solvate thereof, optionally in association with one or more pharmaceutically acceptable carriers for use as therapy for depression and related disorders
